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Inflammation as stroke risk factor: atherosclerosis
Proinflammatory
players
Atherosclerosis is a chronic disease in which inflammatory and immune responses 
contribute to the initiation, progression, and destabilization of atherosclerotic lesions
Inflammatory and immune responses in atherosclerosis
Infection can trigger vascular events and stroke
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Chronic Th1-type peripheral infection contributes to brain 
injury after stroke
Denés et al., (2010)
J Neurosci. 30:10086-95
2h                              10h                             36h
Inflammation and innate immunity after brain ischemia
1) Reaction of resident cells: glial reaction
2) Adhesion and infiltration of leukocytes
3) Molecular players: cytokines, chemokines, 
adhesion molecules, TLR, complement…
Dirnagl et al. 1999; TINS 22:391-7 Rojas et al, 07 JCBF 27:1975
Low plasma levels of IL-10 predict bad
outcome and neurological impairment
Vila et al. (2003) Stroke
Cytokines as clinical predictors of outcome in the clinics
-Eritrocyte sedimentation rate
-Reactive C protein (CRP) 
-Interleukin-6
-Tumor necrosis fator (TNF) 
-Intercellular adhesion molecule (ICAM-1)
Mean ± SD delay to sampling 8.2 ± 5.7 hrs
High plasma levels of IL-6 and TNF-α
predict bad outcome and
neurological impairment
Castellanos et al. (2002) Stroke
P<0.001 P=0.001Pg/mL
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Stroke activates an innate immune response that
contributes to brain injury
Clinical deterioration
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COMPLEMENT
TOLL-LIKE RECEPTORS
Innate Immune System
Pattern recognition receptors trigger inflammation
Kariko et al 2004 JCBF 24:1288
Innate Immunity
Cell Associated Receptors
TLR expression is induced in 
the brain after ischemia
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TLR-4 contributes to the brain
lesion after ischemia in mice
Caso et al., Circulation. 2007
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TLRs in monocytes
of stroke patients 
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The Complement System
The complement system is activated in rodents after brain ischemia
De Simoni et al., 2004, Am J Pathol 164:1857-63
The complement system is activated in patients with acute stroke
Mocco et al., 2006, Neurosurgery 59:28-33 and Circ Res 99:209-17
Mice
2-h MCAO +48h reperfusion in mice WT / MBLnullThe Lectin Pathway
Experimental 
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Baseline characteristics in the study population (n=135) according to MBL genotype 
MBL-low MBL-sufficient
N=24 (18%) N=111 (82%) p value
Age (mean, SD), yrs 73.9 (12.8) 72.9 (11.5) 0.67
Male, no.(%) 9 (37.5) 59 (53.2) 0.16
Active smoking, no. (%) 3 (12.5) 20 (18.0) 0.77
Hypertension, no. (%) 12 (50.0) 73 (65.8) 0.15
Diabetes, no. (%) 6 (25.0) 24 (21.6) 0.72
Coronary heart disease, no. (%) 2 (8.3) 15 (13.5) 0.49
Previous stroke, no. (%) 4 (16.7) 19 (17.1) 1.00
Peripheral artery disease, no. (%) 2 (8.3) 9 (8.1) 1.00
Admission NIHSS score, no. (%) 0.10
0 to 6 5 (21) 14 (13)
7 to 17 13 (54) 56 (51)
>17 6 (25) 41 (37)
Cervera et al., 2010
The Lectin Pathway
Manose-Binding Lectin (MBL) in Stroke patients: 
MBL-sufficient and MBL-low genotypes
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P=0.008
MBL in stroke patients
MBL DEFICIENT MBL NORMAL
% GOOD OUTCOME AT 3 MONTHS
60% MBL-low and 
30% MBL-sufficient 
patients reached functional 
independence 
(mRS score 0 to 2) 
(χ2, p=0.008) 
The cellular players
Huang et al. (2006) 
Surg. Neur. 66 232–245
Glial reaction and macrophage infiltration
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Circulation 113:2105-12
Planas & Chamorro, 2009
Regulatory T cells
protect the brain
after stroke
Liesz, et al. Nat. Med. (2008)
Stroke-associated infection
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Immunodepression in human stroke?
Circulating monocytes
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CD14highCD16-, OR 1,29 1,38 1,40
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Immunomodulatory strategies
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IL-1RA
TLR4 antagonists
Treg cells
Monocyte subtypes
Ischemic tolerance
Antibiotics
Corticosteroids
Heparin
Statins
IL-1RA
+ 78% infections
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2005;76(10):1366-72
STROKE
Normal life
Death
Disability
Neurorepair & recovery
Functional
recovery
Neuronal repair?
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Innate immune responses affect
neurogenesis and repair
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Role of inflammation and innate immunity in neurogenesis
Baron et al. 2008 
FASEB J. 22:2843
Deficiency in TLR4 in the early postnatal retina 
results in increased neuronal differentiation
Shechter et al 08 J Cell Biol 183:393
Rolls et al 2007
Nat Cell Biol. 9:1031
Impaired neurogenesis in TLR2-
deficient mice
Rutkowski et al., Immunol Cell Biol. 2010 Apr 20.
Complement affects neurogenesis and regeneration
Conclusions
• Innate immunity plays an active role in inflammation before and 
after stroke and influences brain damage .
• Genetics may affect the features and magnitude of inflammatory
and/or immune responses: towards a more personalised treatment?
• Stroke is accompanied by immunosuppression favouring infection
• Inflammation and innate immunity affect neurogenesis and repair. 
Understanding the intensity of the signals and their time course is 
essential for designing therapeutic strategies
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